Event Title
Legislative Update- A comparison of Legislative Proposals and Implications
Start Date
4-21-2009 10:45 AM
End Date
4-21-2009 12:00 PM
Description
Ann Witt, JD, is currently Health Counsel for the House Committee on Energy and Commerce. Since 2002, she has worked for Congressman Henry Waxman. Prior to this role, Ms. Witt held a position with FDA and took a 7-month leave of absence in 2000 to work as staff director of an investigation for the World Health Organization into covert attempts by the tobacco industry to influence WHO. While at FDA, she spent one year as Acting Director of the Division of Drug Marketing and Advertising in CDER, then joined the Office of the Commissioner in 1992, working on a variety of issues including tobacco regulation, advisory committees and conflicts of interest, and pediatric labeling for new drugs. Ms. Witt joined FDA in 1980, working for the Office of the Chief Counsel until 1991, where her primary responsibilities included providing legal counseling on new drug and device issues to FDA’s Center for Drug Research and Evaluation (CDER) and Center for Devices and Radiological Health (CDRH). Before joining FDA, she clerked for the Ninth Circuit Court of Appeals, Staff Attorney’s Office. Ms. Witt earned an AB from Bryn Mawr College, and a JD from Stanford Law School.
Legislative Update- A comparison of Legislative Proposals and Implications
Ann Witt, JD, is currently Health Counsel for the House Committee on Energy and Commerce. Since 2002, she has worked for Congressman Henry Waxman. Prior to this role, Ms. Witt held a position with FDA and took a 7-month leave of absence in 2000 to work as staff director of an investigation for the World Health Organization into covert attempts by the tobacco industry to influence WHO. While at FDA, she spent one year as Acting Director of the Division of Drug Marketing and Advertising in CDER, then joined the Office of the Commissioner in 1992, working on a variety of issues including tobacco regulation, advisory committees and conflicts of interest, and pediatric labeling for new drugs. Ms. Witt joined FDA in 1980, working for the Office of the Chief Counsel until 1991, where her primary responsibilities included providing legal counseling on new drug and device issues to FDA’s Center for Drug Research and Evaluation (CDER) and Center for Devices and Radiological Health (CDRH). Before joining FDA, she clerked for the Ninth Circuit Court of Appeals, Staff Attorney’s Office. Ms. Witt earned an AB from Bryn Mawr College, and a JD from Stanford Law School.
